First-in-class ultralong-target-residence-time p38α inhibitors as a mitosis-targeted therapy for colorectal cancer

DSpace Repository

First-in-class ultralong-target-residence-time p38α inhibitors as a mitosis-targeted therapy for colorectal cancer

Author: Rudalska, Ramona; Harbig, Jule; Forster, Michael; Woelffing, Pascal; Esposito, Aylin; Kudolo, Mark; Botezatu, Adelina; Haller, Vanessa; Janssen, Nicole; Holzmayer, Samuel; Nahidino, Philipp; Trompak, Omelyan; Pantsar, Tatu; Kronenberger, Thales; Yurttas, Can; Rist, Elke; Weber, Alexander N. R.; Dahlke, Marc H.; Ott, German; Koenigsrainer, Alfred; Rothbauer, Ulrich; Maerklin, Melanie; Muerdter, Thomas; Schwab, Matthias; Singer, Stephan; Zender, Lars; Laufer, Stefan; Dauch, Daniel
Tübinger Autor(en):
Rudalska, Ramona
Harbig, Jule
Forster, Michael
Esposito, Aylin
Kudolo, Mark
Botezatu, Adelina
Haller, Vanessa
Janssen, Nicole
Holzmayer, Samuel
Nahidino, Philipp
Trompak, Omelyan
Pantsar, Tatu
Kronenberger, Thales
Yurttas, Can
Rist, Elke
Weber, Alexander N. R.
Rothbauer, Ulrich
Schwab, Matthias
Singer, Stephan
Zender, Lars
Laufer, Stefan
Wölffing, Pascal
Königsrainer, Alfred
Märklin, Melanie
Mürdter, Thomas E.
Dauch, Daniel Alexander
Published in: Nature Cancer (2025), Bd. 6, H. 2
Verlagsangabe: Berlin : Nature Portfolio
Language: English
Full text: http://dx.doi.org/10.1038/s43018-024-00899-7
ISSN: 2662-1347
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)